InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Jayagopal Ashwath. Insider active across 2 companies, notably Ocuphire Pharma, Inc.. Aggregated, 8 disclosures have been recorded. Breakdown: 1 buy · 2 sells. Total volume traded: €56k. History available since 12 February 2024. The latest transaction was disclosed on 23 April 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Jayagopal Ashwath is Chief Scientific & Dev. Ofc. at Opus Genetics, Inc. and Ocuphire Pharma, Inc. He has filed 8 reports in total, and across the recent sample of 8 filings, the transactions run from 2024-02-14 to 2026-04-27, with EUR 5,707 of buys and EUR 50,168 of sells, and the modal transaction nature is Attribution.